Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin C Taylor

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Current Pharmaceutical Design|February 11, 2020
Lipophilic Guanylhydrazone Analogues as Promising Trypanocidal Agents: An Extended SAR StudyVasiliki Pardali, Erofili Giannakopoulou, Dimitrios-Ilias Balourdas, et al.
Medchemcomm|July 16, 2019
Scaffold hybridization strategy towards potent hydroxamate-based inhibitors of <i>Flaviviridae</i> viruses and <i>Trypanosoma</i> speciesErofili Giannakopoulou, Vasiliki Pardali, Efseveia Frakolaki, et al.
Scientific Reports|November 2, 2017
Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazoleMônica C Campos, Jody Phelan, Amanda F Francisco, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 15, 2019
Exploiting Genetically Modified Dual-Reporter Strains to Monitor Experimental Trypanosoma cruzi Infections and Host-Parasite InteractionsMartin C Taylor, Amanda F Francisco, Shiromani Jayawardhana, et al.
Current Pharmaceutical Design|November 25, 2020
Bioluminescent:Fluorescent Trypanosoma cruzi Reporter Strains as Tools for Exploring Chagas Disease Pathogenesis and Drug ActivityMartin C Taylor, Alexander I Ward, Francisco Olmo, et al.
Molecules (Basel, Switzerland)|January 17, 2018
Tetrasubstituted Imidazolium Salts as Potent Antiparasitic Agents against African and American TrypanosomiasesOuldouz Ghashghaei, Nicola Kielland, Marc Revés, et al.
Clinical Microbiology Reviews|November 15, 2024
Animal models for exploring Chagas disease pathogenesis and supporting drug discoveryArchie A Khan, Martin C Taylor, Amanda Fortes Francisco, et al.
Plos Pathogens|August 23, 2021
Local association of Trypanosoma cruzi chronic infection foci and enteric neuropathic lesions at the tissue micro-domain scaleArchie A Khan, Harry C Langston, Fernanda C Costa, et al.
Pathogens (Basel, Switzerland)|November 25, 2023
Cardiac Abnormalities in a Predictive Mouse Model of Chagas DiseaseAmanda Fortes Francisco, Giovane R Sousa, Mhairi Vaughan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 30, 2021
Synthesis, antiproliferative and antitrypanosomal activities, and DNA binding of novel 6-amidino-2-arylbenzothiazolesLivio Racané, Valentina Rep, Sandra Kraljević Pavelić, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Current Pharmaceutical Design|February 11, 2020
Lipophilic Guanylhydrazone Analogues as Promising Trypanocidal Agents: An Extended SAR StudyVasiliki Pardali, Erofili Giannakopoulou, Dimitrios-Ilias Balourdas, et al.
Medchemcomm|July 16, 2019
Scaffold hybridization strategy towards potent hydroxamate-based inhibitors of <i>Flaviviridae</i> viruses and <i>Trypanosoma</i> speciesErofili Giannakopoulou, Vasiliki Pardali, Efseveia Frakolaki, et al.
Scientific Reports|November 2, 2017
Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazoleMônica C Campos, Jody Phelan, Amanda F Francisco, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 15, 2019
Exploiting Genetically Modified Dual-Reporter Strains to Monitor Experimental Trypanosoma cruzi Infections and Host-Parasite InteractionsMartin C Taylor, Amanda F Francisco, Shiromani Jayawardhana, et al.
Current Pharmaceutical Design|November 25, 2020
Bioluminescent:Fluorescent Trypanosoma cruzi Reporter Strains as Tools for Exploring Chagas Disease Pathogenesis and Drug ActivityMartin C Taylor, Alexander I Ward, Francisco Olmo, et al.
Molecules (Basel, Switzerland)|January 17, 2018
Tetrasubstituted Imidazolium Salts as Potent Antiparasitic Agents against African and American TrypanosomiasesOuldouz Ghashghaei, Nicola Kielland, Marc Revés, et al.
Clinical Microbiology Reviews|November 15, 2024
Animal models for exploring Chagas disease pathogenesis and supporting drug discoveryArchie A Khan, Martin C Taylor, Amanda Fortes Francisco, et al.
Plos Pathogens|August 23, 2021
Local association of Trypanosoma cruzi chronic infection foci and enteric neuropathic lesions at the tissue micro-domain scaleArchie A Khan, Harry C Langston, Fernanda C Costa, et al.
Pathogens (Basel, Switzerland)|November 25, 2023
Cardiac Abnormalities in a Predictive Mouse Model of Chagas DiseaseAmanda Fortes Francisco, Giovane R Sousa, Mhairi Vaughan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 30, 2021
Synthesis, antiproliferative and antitrypanosomal activities, and DNA binding of novel 6-amidino-2-arylbenzothiazolesLivio Racané, Valentina Rep, Sandra Kraljević Pavelić, et al.
Pageof 10